Expandable Ingestible Pill for Intestinal Wall Contact

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current ingestible capsules for medication delivery in the gastrointestinal tract face challenges in ensuring effective contact and absorption of medications at the intestinal wall, as they often lack efficient mechanisms for sustained contact and uniform delivery.

Innovation Solution

The development of an ingestible pill with an enteric coating that dissolves in the small intestine, featuring a medication-delivery device with a patch and needles that expand to ensure good contact with the intestinal wall, allowing for enhanced medication uptake and delivery through penetration or adhesion, utilizing pH-sensitive coatings and shape-memory materials for controlled expansion.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of moving object

If the capsule is designed to dissolve in the gastrointestinal tract, then medication delivery is enabled, but the capsule cannot maintain structural integrity for sustained contact with the intestinal wall

Engineering Contradiction:
Improvesustained contact timeVSAvoidcapsule structural integrity
Core Design Contradiction:
Duration of action of moving objectVSStability of the object's composition

Solution Approach 1:

The capsule is divided into two functional components: an enteric coating layer that dissolves after gastric passage, and an inner core containing the medication-delivery element. This segmentation allows the coating to provide temporary structural integrity during transit while the core maintains its shape for sustained contact with the intestinal wall after dissolution of the coating.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The medication-delivery element is pre-compressed into a compact form that fits within the capsule during ingestion. Upon dissolution of the enteric coating in the small intestine, the element automatically expands to its operational configuration, establishing sustained contact with the intestinal wall without requiring additional action from the subject.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If the capsule expands to ensure good contact with the intestinal wall, then medication absorption is improved, but the capsule may obstruct food passage

Engineering Contradiction:
Improvemedication absorption efficiencyVSAvoidfood passage obstruction
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The medication-delivery element is designed to expand locally at the site of intestinal contact, forming a flattened configuration with a large surface area that ensures reliable medication delivery. This localized expansion occurs only after the element has passed through the stomach and entered the small intestine, where it contacts the intestinal wall and delivers medication without obstructing normal food passage through the digestive tract.

Inventive Principle:
Principle #3Local quality

3Ease of operation

If the capsule is compressed for ingestion, then it is easy to swallow, but the surface area for medication contact with the intestinal wall is reduced

Engineering Contradiction:
Improveingestion easeVSAvoidcontact surface area
Core Design Contradiction:
Ease of operationVSArea of stationary object

Solution Approach 1:

The medication-delivery element transitions dynamically from a compressed state during ingestion to an expanded state upon contact with the small intestine. This dynamic transformation allows the element to be easily swallowed in a compact form while subsequently expanding to provide a large contact surface area for effective medication delivery to the intestinal wall.

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This design enables sustained and efficient delivery of medications by ensuring prolonged contact with the intestinal wall, improving absorption rates and minimizing residual medication, while maintaining the pill's ability to pass through the digestive system without obstructing food passage.

Implementation Method 1

an enteric coating configured to dissolve in a small intestine of the subject

Methodology Applied
Scientific EffectpH-sensitive dissolution: Chemical Bonding

Implementation Method 2

utilizing pH-sensitive coatings and shape-memory materials for controlled expansion

Methodology Applied
Scientific EffectShape memory effect: Shape Memory Polymer

Data Source

PatentEP3836906B1Expandable drug delivery pill
Publication Date: 2023.03.29 ALMA THERAPEUTICS LTD
  • EP3836906B1 patent drawingFigure 1A~1B
  • EP3836906B1 patent drawingFigure 2A~2B
  • EP3836906B1 patent drawingFigure 2C~2D

AI summary

An ingestible pill (1220, 1320) is provided including a medication-delivery device (1224, 1324), which is configured to deliver a medication (52) and includes a patch (1230, 1330) (a) having upper and lower surfaces (1232, 1234) that face in generally opposite directions, (b) disposed within an enteric coating (22) in a compressed shape (1242), (c) configured to assume an expanded shape (1244) after the enteric coating (22) dissolves. The patch (1230, 1330) includes a chamber (1270) defined by (a) a substantially water- impermeable and substantially gas-impermeable, elastic layer (1274) shaped so as to define at least one window (1276) therethrough, and (b) a liquid-permeable and substantially gas-impermeable wetting layer (1278), which entirely covers the at least one window (1276) and is sealed to the elastic layer (1274) around the at least one window (1276). The patch (1230, 1330) further includes, disposed within the chamber (1270), a gas-generating substance (1280) that produces gas upon contact with liquid. Other embodiments are also described.